What is HHC and what does it do?

Hexahydrocannabinol (HHC) is a semi-synthetic cannabinoid derived from hemp that has gained significant attention in the cannabis market since 2022. HHC is created through a hydrogenation process that adds hydrogen atoms to Delta-9 THC, resulting in a more stable compound with a longer shelf life than traditional THC products. HHC produces psychoactive effects similar to Delta-9 THC, though typically reported as milder. Users commonly describe effects including euphoria, relaxation, altered perception, and mild sedation. The potency is generally considered to be 70-80% that of Delta-9 THC, making it less intense than traditional cannabis but more potent than CBD. The compound exists in two forms: 9R-HHC (active) and 9S-HHC (inactive). Commercial HHC products typically contain a mixture of both, with the ratio affecting overall potency. Most HHC products on the market contain approximately 60-70% active 9R-HHC. HHC's legal status remains complex and varies by jurisdiction. Since it can be derived from hemp (containing less than 0.3% Delta-9 THC), some manufacturers argue it falls under the 2018 Farm Bill's hemp legalization. However, the DEA and various state regulators have raised concerns about synthetic cannabinoids, leading to regulatory uncertainty. The HHC market has experienced rapid growth, with products including vapes, edibles, and tinctures becoming widely available at hemp retailers and online. However, quality control remains a significant concern, as manufacturing processes vary widely between producers. **Disclaimer: This information is for educational purposes only and should not be considered medical advice. HHC products have not been evaluated by the FDA and may cause impairment. Consult with healthcare professionals before use, especially if you have medical conditions or take medications. Laws regarding HHC vary by location.**